Poly Medicure Limited
POLYMED · 531768 · Healthcare · Medical Equipment & Supplies
- Market cap
- Rs 14,818 Cr
- P/E
- 47.02x
- P/B
- 4.77x
- 52W high / low
- Rs 2,094.3 / Rs 1,182
About Poly Medicure
Poly Medicure Limited is listed on the NSE under the symbol POLYMED and on the BSE under scrip code 531768. It is classified in the Healthcare sector, industry: Medical Equipment & Supplies. It is a constituent of BSE 500, NIFTY 500 and NIFTY Smallcap 250. The company listed on 7 Dec 2011 and has a face value of Rs 5.
The latest available end-of-day price is Rs 1,461.9 (−0.96% on the day), for a market capitalisation of Rs 14,818 Cr. Trailing P/E is 47.02x and price-to-book is 4.77x. The 52-week range is Rs 1,182 to Rs 2,094.3. The latest price is 31% of the way from the 52-week low to the 52-week high.
Against the 5-company comparison set from the official BSE basic industry Medical Equipment & Supplies, its market capitalisation is 3.1 times the peer median of Rs 4,850 Cr, and its P/E of 47.02x compares with a peer median of 59.23x. The comparison set is chosen mechanically from the exchange classification; it is not a ranking.
Latest annual results
For FY26 (year ended 31 Mar 2026), Poly Medicure Limited reported revenue of Rs 1,875 Cr and net profit of Rs 321 Cr, with a net margin of 17.10% and earnings per share of Rs 31.79 (consolidated statements).
Year-on-year change: revenue +13.44%; net profit −5.27%; EPS −6.86%. Three-year compound annual growth rate: revenue +20.11%; net profit +21.39%.
At the same date the balance sheet shows total assets of Rs 3,919 Cr, shareholders' equity of Rs 3,106 Cr, total debt of Rs 342 Cr, cash of Rs 51.2 Cr, a debt-to-equity ratio of 0.11 and operating cash flow of Rs 241 Cr.
On a trailing-twelve-month basis the filings add up to revenue of Rs 1,997 Cr, net income of Rs 313 Cr and a net margin of 15.67%.
Shareholding pattern
In the shareholding pattern for 30 Sept 2026, Poly Medicure Limited's ownership is split: promoters 62.42%; foreign institutional investors (FIIs) 5.35%; domestic institutional investors (DIIs) 15.90%; retail and other shareholders 16.33%.
Compared with the filing for 30 Jun 2026: promoter holding 0.00 percentage points; FII holding −0.22 percentage points; DII holding −0.18 percentage points.
The same filing lists reported promoter pledge of 0.00% and 74,153 shareholders on record.
Recent filings and corporate actions
103 BSE corporate announcements were filed by Poly Medicure Limited in the past twelve months; the most frequent category is "Company Update" (82). The most recent is "Poly Medicure Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to cons…" (Board Meeting), filed on 29 Oct 2026.
The disclosed corporate-action timeline lists 5 entries: dividend (5). The latest is a dividend (Final Dividend - Rs. - 3.5000) with ex-date 28 Aug 2026.
Figures are raw disclosures from official NSE/BSE and SEBI filings plus mechanically computed ratios, restated in words. This is research data, not investment advice, a rating or a recommendation; DalalOS is not a SEBI-registered investment advisor.
More
Peer comparison
Official BSE basic industry: Medical Equipment & Supplies. Limited to companies within a 0.1x–10x market-cap band.
Edit columns
| Poly Medicure LimitedThis company | Rs 1,461.9 | Rs 14,818 Cr | Rs 2,109 Cr | Rs 313 Cr | 47.02x | 10.73% |
| Molbio Diagnostics Limited | Rs 1,302.6 | Rs 14,688 Cr | — | — | 88.19x | — |
| Sahajanand Medical Technologies Limited | Rs 476.55 | Rs 4,850 Cr | — | — | 71.45x | — |
| Fischer Medical Ventures Limited | Rs 25.93 | Rs 1,697 Cr | Rs 373 Cr | Rs 29.8 Cr | 10.80x | 8.25% |
| Tarsons Products Limited | Rs 303.95 | Rs 1,617 Cr | Rs 468 Cr | Rs 11.1 Cr | — | 1.75% |
| Median | Rs 476.55 | Rs 4,850 Cr | Rs 468 Cr | Rs 29.8 Cr | 59.23x | 8.25% |
Peers are selected mechanically from the official BSE industry hierarchy and current market-cap band. This is a comparison set, not a ranking or recommendation.
Companies related to Poly Medicure
Same official industry (Medical Equipment & Supplies)
Other Healthcare companies of a similar market capitalisation
- Pfizer LimitedPFIZER · Market cap Rs 17,201 Cr
- Eris Lifesciences LimitedERIS · Market cap Rs 16,139 Cr
- Syngene International LimitedSYNGENE · Market cap Rs 16,091 Cr
- Vijaya Diagnostic Centre LimitedVIJAYA · Market cap Rs 15,066 Cr
- Jubilant Pharmova LimitedJUBLPHARMA · Market cap Rs 14,947 Cr
- Indegene LimitedINDGN · Market cap Rs 14,272 Cr
- Natco Pharma LimitedNATCOPHARM · Market cap Rs 14,097 Cr
- Concord Biotech LimitedCONCORDBIO · Market cap Rs 12,874 Cr
Companies are grouped mechanically from the exchange classification and listed by market capitalisation. This is a comparison set, not a ranking or recommendation.